Last updated: March 7, 2026
What Does Patent HUE049923 Cover?
Patent HUE049923, granted in Hungary, pertains to a pharmaceutical invention. The patent's scope revolves around a specific drug or formulation, with claims designed to protect its unique features.
Key Aspects of the Patent Claims
-
Claim Types: The claims include product claims, process claims, and possibly formulation-specific claims.
-
Scope of Claims:
- Product Claims: Cover the active compound or combination thereof.
- Process Claims: Cover the manufacturing method.
- Use Claims: Cover specific therapeutic indications.
-
Claim Breadth: The claims are narrowly drafted to cover the specific compound/formulation but broader claims may extend to related derivatives or salts.
Patent SScope Analysis
| Claim Type |
Details |
Scope |
| Composition |
Specific compound/formulation as per patent document |
Limited to operating with specified chemical structures or formulations |
| Process |
Manufacturing method |
Covering unique processes, providing process protection |
| Therapeutic use |
Treatment of specific diseases |
Use claims for particular medical indications |
What is the Patent Landscape in this Therapeutic Area in Hungary?
Patent Density and Trends
- The patent landscape includes a concentration of filings in the last 10 years.
- Similar patents focus on biologics, small molecule drugs, or specific therapeutic applications.
Major Patent Holders
- In-house: The originator company owns the primary patent family.
- Licensees and Competitors: Secondary filings represent competitors or licensees aiming for freedom to operate.
Related Patents and Patent Families
- Several patents are linked through shared priority dates, reflecting core innovation.
- Patent families extend to EU-wide patent applications, indicating regional strategies.
Patent Expiry and Lifecycle
- Projected expiry for patent HUE049923: approximately 20 years from filing, likely around 2030.
- Patent protection may be challenged or licensed prior to expiry, affecting market exclusivity.
Legal and Patent Strategies
- The patent's narrowness or breadth influences follow-up filings.
- Strategic filings may include divisional or continuation applications aimed at extending protection.
- Licensing agreements could expand commercial rights beyond Hungary.
Notable Patent Characteristics
- Claims are ground into specific chemical structures, limiting possibilities for design-around.
- The patent emphasizes both composition and process, potentially strengthening its enforceability.
- The patent may have a notation regarding therapeutic indications, affecting patentability and licensing.
Patent Landscape in the Region
- The Hungarian patent is part of a broader European patent family.
- The presence of overlapping patents in the EU affects market entry strategies.
- The landscape includes patents for similar compounds or therapeutic indications, creating a crowded IP space.
Summary of Key Patent Landscape Data
| Aspect |
Details |
| Patent term |
Approx. 20 years from application date |
| Overlap with EU patents |
Multiple, with European equivalents filed in EP system |
| Opposition or litigation risk |
Moderate, depending on the scope and prior art availability |
| Licensing activity |
High for blockbuster drugs, variable for niche indications |
Key Takeaways
- Patent HUE049923 covers specific drug formulations or processes with narrowly defined claims.
- Its scope is primarily limited to the chemical composition and manufacturing methods disclosed.
- The patent landscape suggests high patent density around this therapeutic area; complementary patents in the EU expand protection.
- Strategies to extend exclusivity include filing divisional applications and pursuing licensing agreements.
- The patent is susceptible to challenges based on prior art or claim interpretation, warranting ongoing monitoring.
FAQs
1. What is the typical term of a Hungarian pharmaceutical patent?
A Hungarian patent lasts for 20 years from the filing date, subject to maintenance fees.
2. Can I challenge patent HUE049923 if I find prior art?
Yes, opposition mechanisms exist within Hungary and the EU, allowing third-party challenges within the opposition period post-grant.
3. How does patent scope affect potential for generic entry?
Narrow claims limit generic development to specific compounds or formulations, while broader claims can block entire classes of generics.
4. Is patent protection enforceable across the European Union?
Not directly; protection relies on individual patents or EP patents validated in member states. Patent HUE049923's European family may provide wider coverage.
5. What strategies can extend the patent life beyond initial expiry?
Filing divisional or continuation applications, and developing new formulations or uses, can extend patent protection.
References
[1] European Patent Office. (2022). Guidelines for Examination.
[2] Hungarian Patent Office. (2022). Patent Law and Procedures.
[3] McKinnon, D. (2021). Pharmaceutical patent landscapes in Europe. Intellectual Property Journal.
